Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Ecotoxicology and Environmental Safety|January 27, 2026
The mycotoxin zearalenone and its metabolite α-zearalenol impair anticancer activity of doxorubicin in estrogen receptor-positive breast cancer cellsJudith Gufler, Maryse Max, Doris Marko, et al.
Toxicology|December 26, 2024
Opposing effects of mycotoxins alternariol and deoxynivalenol on the immunomodulatory effects of oxaliplatin and triapineJudith Gufler, Petra Heffeter, Christian R Kowol, et al.
Dalton Transactions (Cambridge, England : 2003)|October 7, 2021
Liposomal formulations of anticancer copper(II) thiosemicarbazone complexesMarlene Mathuber, Sonja Hager, Bernhard K Keppler, et al.
Cellular & Molecular Immunology|February 26, 2024
Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signalingZhengnan Cai, Wan Li, Sonja Hager, et al.
Oncotarget|September 8, 2016
Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signalingWalter Miklos, Petra Heffeter, Christine Pirker, et al.
Metallomics : Integrated Biometal Science|July 28, 2023
Human serum albumin as a copper source for anticancer thiosemicarbazonesMartin Schaier, Enrico Falcone, Tomas Prstek, et al.
Bioconjugate Chemistry|August 11, 2017
Multifunctional α<sub>v</sub>β<sub>6</sub> Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell TargetingAnne C Conibear, Sonja Hager, Josef Mayr, et al.
Scientific Reports|November 23, 2018
Biological activity of Pt<sup>IV</sup> prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysisSilvia Alonso-de Castro, Alessio Terenzi, Sonja Hager, et al.
Pageof 3